6505--PHARMACY-CHEMO COMPOUNDING
ID: 36C24224Q0819Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF242-NETWORK CONTRACT OFFICE 02 (36C242)ALBANY, NY, 12208, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/e4de89f7f568401f8ba8be2af5c66837/view
Timeline
    Description

    The Department of Veterans Affairs (VA) Network Contracting Office 2 intends to award a sole source contract to Optum Pharmacy for the provision of chemotherapy services at the New Jersey Veterans Affairs Medical Center (NJ VAMC). This contract is necessitated by current limitations in local compounding of hazardous medications and will cover one base year with four optional years. The contractor is required to ensure compliance with drug stability during shipping, timely delivery of chemotherapy products by 10:30 AM on treatment days, adherence to aseptic preparation techniques in accordance with USP 797 and USP 800 regulations, and compatibility with specific medical equipment. Interested firms that believe they can meet these requirements must submit written notifications by September 12, 2024, at 9:00 AM ET via email to Lee Kern at Lee.Kern@va.gov, as telephone inquiries will not be accepted.

    Point(s) of Contact
    Lee KernContract Specialist
    (607) 664-4748
    Lee.Kern@va.gov
    Files
    Title
    Posted
    36C24224Q0819_1.docx
    The Department of Veterans Affairs (VA) Network Contracting Office 2 intends to award a sole source contract to Optum Pharmacy for chemotherapy provision at the New Jersey Veterans Affairs Medical Center (NJ VAMC) due to current limitations in local compounding of hazardous medications. This contract will cover one base year with four optional years. Key deliverables include compliance with drug stability requirements for shipping, timely delivery of chemotherapy products, adherence to aseptic preparation techniques following USP 797 and USP 800 regulations, and compatibility with specific medical equipment. Despite being a sole source notice, firms can respond if they can meet these requirements before the September 12, 2024 deadline. Responses must be submitted via email, with no telephonic inquiries allowed. This document underscores the VA's commitment to ensuring continuous chemotherapy services while adhering to safety and regulatory standards.
    Lifecycle
    Title
    Type
    6505--PHARMACY-CHEMO COMPOUNDING
    Currently viewing
    Sources Sought
    Similar Opportunities
    J065--INTENT TO SOLE SOURCE OMNICELL PHARMACY EQUIPMENT PM&R
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a sole-source contract for preventive maintenance of OMNICELL pharmacy equipment and Omni Center Server software, specifically at the Phoenix VA Medical Center. This procurement is necessary to ensure the ongoing functionality and reliability of critical pharmacy equipment, which plays a vital role in the healthcare services provided to veterans. Interested vendors must submit capability statements demonstrating relevant past performance and licensing status by 12:00 PM Pacific Time on September 20, 2024, and should direct inquiries to Contract Specialist Charity Cazee at charity.cazee@va.gov.
    J066-- Omnicell Services | Philadelphia VAMC
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to establish a sole-source contract with OmniCell, Inc. for support services related to OmniCell equipment at the Philadelphia VA Medical Center. This firm-fixed-price order aims to ensure uninterrupted access to essential services, thereby fulfilling the VA's operational requirements. The procurement is critical for maintaining the functionality of medical equipment that supports veteran care at the facility. Interested parties can direct inquiries to Contracting Officer Ashley Zeccardo at ashley.zeccardo@va.gov or by phone at 484-576-6002, with a response deadline set for September 18, 2024, under solicitation number 36C24424Q1012.
    6505--Supply, Axumin-Axumin + Cerianna Medicines - Nuclear Med, CLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to solicit and negotiate exclusively with PetNet Solutions and TrillaMed for the supply of three proprietary radiopharmaceuticals—Axumin, Amyvid, and Cerianna—for the Nuclear Medicine Service at the Louis Stokes Cleveland VA Medical Center. These products are critical for diagnosing recurrent prostate cancer, breast cancer, and Alzheimer’s disease, necessitating the use of a local radiopharmacy due to their radioactive nature and short shelf life. Interested vendors may submit their capabilities until September 18, 2024, to determine if a competitive procurement process is feasible, with all inquiries directed to Contract Specialist Don Caldwell at don.caldwell@va.gov.
    6505--PET MRI Radiopharmaceuticals
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center in Detroit, MI. This contract will provide essential radiopharmaceuticals necessary for conducting nuclear medicine exams on PET MRI patients, with a one-year purchase order scheduled from October 1, 2024, to September 30, 2025. The procurement includes specific products such as Cu64 Dotatate, F18 PSMA, F18 FDG, and F18 Vizamyl, with estimated annual quantities outlined in the opportunity. Interested parties may express their interest and demonstrate their capability to meet the requirements by the deadline of September 17, 2024, by contacting Contracting Officer Jeffrey Rozema at jeffrey.rozema@va.gov.
    5860--Varian FullScale on Premise Base Year (VA-25-00001444)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole source contract for the Varian FullScale on Premise system to Varian Medical Systems, Inc. This procurement is essential for the renewal of an IT hosting solution that supports Varian software applications and server infrastructure at the Richard L. Roudebush VA Medical Center, ensuring continued functionality and enhanced clinical availability alongside existing Varian oncology systems. The contract, justified under Section 41 U.S.C. 3304(a)(1) due to the unique capabilities of Varian, aims to minimize operational disruptions and costs associated with switching vendors. Interested parties can reach Contract Specialist Erin Butler at erin.butler3@va.gov, with a response deadline set for September 18, 2024, at 3:00 PM Eastern Time.
    Q522--PHARMACUTICAL, STL 657-24-3-1642-0121, (VA-25-00001168)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Sources Sought Notice for a contract involving the provision of a proprietary radiopharmaceutical agent, Pluvicto, for the St. Louis VA Medical Center. This contract will cover a base year plus four option years for the supply of Lutetium LU 177 Vipivvotide Tetraxetan, which is critical for treating adult patients with prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. The selected contractor will be responsible for administering this radioactive diagnostic therapy via IV, with all contract administration functions retained by the Department of Veterans Affairs. Interested parties must submit their responses by September 20, 2024, at 3:00 PM CST, to Michael P. Murphy at michael.murphy7@va.gov, including their Unique Entity ID and relevant qualifications.
    6515--OptiLight
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Veterans Health Administration and Network Contracting Office 6, intends to award a sole-source contract to Milling Medical LLC for the procurement of the Lumenis OptiLight system, a specialized FDA-approved treatment for dry eyes. The contract will involve the delivery of Lumenis BE OptiLight equipment and a Treatment Kit to the Fredericksburg HealthCare Clinic in Virginia, with the effective contract date set for September 15, 2024. This procurement is critical as the Lumenis OptiLight is the only product of its kind that meets the government's needs for treating dry eyes, as determined through market research. Interested vendors have a limited window of three days to submit capability statements to the contracting officer, Gordon E. Burns, via email at Gordon.Burns@va.gov, with no obligation for the government to procure the services mentioned.
    6515--Omnicell Supply Dispensing Cabinets/Windows 10 O/S
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Omnicell Supply Dispensing Cabinets and Windows 10 Operating System, managed by the Network Contract Office 22. The solicitation, identified as Request for Quotes (RFQ) 36C26224Q1810, requires vendors to provide not only the cabinets but also ongoing maintenance, repairs, and software updates, with a service term extending from November 1, 2024, to October 31, 2025. This procurement is crucial for enhancing healthcare delivery at the VA Long Beach Healthcare System, ensuring that medical staff have access to reliable dispensing solutions. Interested vendors must submit their offers by September 16, 2024, at 15:00 Pacific Time, and direct any questions to Contracting Officer Victor Oliveros at victor.oliveros@va.gov by September 12, 2024.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the supply of Abiraterone Acetate tablets, a pharmaceutical product critical for various government healthcare facilities, including the VA and DoD. The procurement aims to establish a reliable source through competitive contracting, requiring offerors to provide pricing for a base year and four option years, along with an NDC number for their products. Abiraterone Acetate is essential for treating specific cancers, underscoring the importance of ensuring consistent availability of this medication to support patient care. Interested vendors should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must comply with specific packaging, labeling, and manufacturing standards as outlined in the solicitation document.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.